DXP Enterprises Reports Strong Q4 & FY25 Results, Sales Up 11.9%, EPS Up 27.2%, Positive 2026 Outlook
DXPE has more than doubled off its 52-week low of $67.68.
Summary
DXP Enterprises announced robust financial results for Q4 and fiscal year 2025, with significant increases in sales, net income, and EPS, alongside a strengthened balance sheet and positive outlook for 2026.
Key Events · Earnings and Guidance · DXPE
-
Strong Financial Performance
Fiscal 2025 sales increased 11.9% to $2.0 billion, with diluted EPS rising 27.2% to $5.37. Fourth quarter sales grew 12.0% to $527.4 million, and diluted EPS increased 7.8% to $1.39.
-
Enhanced Profitability
Net income for fiscal 2025 increased 25.8% to $88.7 million, and Adjusted EBITDA grew 17.8% to $225.3 million, demonstrating operating leverage and margin expansion.
-
Strengthened Balance Sheet
The company refinanced its Senior Secured Term Loan B, raising an incremental $205 million and reducing borrowing costs by 50 basis points. DXP ended the year with $303.8 million in cash and a healthy secured leverage ratio of 2.3:1.0.
-
Shareholder Returns & Growth Initiatives
DXP repurchased 0.2 million shares for $17.0 million in fiscal 2025 and completed six acquisitions, signaling confidence and strategic expansion.
Analysis · DXPE · Trade & Services
DXP Enterprises delivered strong financial performance for both the fourth quarter and the full fiscal year 2025, exceeding expectations with double-digit growth in sales, net income, and diluted EPS. The company also strategically refinanced its debt at a lower cost and repurchased shares, indicating financial health and a commitment to shareholder value. Management's positive outlook for 2026, driven by organic growth, acquisitions, and favorable market dynamics, suggests continued momentum. Investors should view these results as a strong indicator of operational execution and future potential.
At the time of this filing, DXPE was trading at $152.46 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $67.68 to $171.70. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.